HomeSKYE • NASDAQ
add
Skye Bioscience Inc
Previous close
$16.14
Day range
$14.01 - $16.01
Year range
$1.44 - $19.41
Market cap
415.61M USD
Avg Volume
36.24K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 4.09M | -55.98% |
Net income | -4.42M | 55.32% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -4.06M | 56.14% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.38M | 4.82% |
Total assets | 11.94M | 31.05% |
Total liabilities | 14.07M | 16.12% |
Total equity | -2.13M | — |
Shares outstanding | 28.06M | — |
Price to book | -94.94 | — |
Return on assets | -74.17% | — |
Return on capital | -237.43% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -4.42M | 55.32% |
Cash from operations | -3.84M | 21.08% |
Cash from investing | -7.02K | -100.12% |
Cash from financing | -22.65K | -166.32% |
Net change in cash | -3.87M | -567.28% |
Free cash flow | -2.12M | 52.52% |
About
Founded
2011
Website
Employees
11